Siparex takes majority stake in Winncare
Context
Siparex has reaffirmed its commitment to Winncare by leading a quaternary LBO to retain control of the medical device manufacturer. This transaction allows Siparex, which originally acquired the company in 2021 via its ETI 5 fund, to extend the maturity of its investment while slightly increasing its ownership stake alongside the management team led by President Laurent Faugères. The deal marks a significant restructuring of the minority capital: IDI, which had been an investor since 2014, and Capza have both exited their positions. They are replaced by Kartesia, which entered the capital through a combination of equity and mezzanine debt after a competitive process managed by the investment bank Amala. The strategic rationale for this "prolongation" is driven by Winncare,s strong performance, having doubled its revenue from €75M to €150M in the last five years through a successful buy-and-build strategy involving four acquisitions. The new capital structure is designed to provide the group with the financial flexibility to launch a new phase of consolidation in Europe and North America. The deal is supported by a new senior debt package provided by Crédit Agricole CIB, while historical minority partners BNP Paribas Développement and Crédit Agricole have maintained their stakes. This operation highlights the "essential" nature of Winncare,s products in a market characterized by high demand for elderly care solutions and professionalized home-care equipment.
The acquisition of Winncare is part of the growth strategy of Siparex, which already has several external growth operations under its belt, notably 123 Elec in 2026.
Winncare, which reported an EBITDA margin of [members only] in 2025, is valued in this transaction at an EV/EBITDA multiple of [members only].
-> Deep-dive in Healthcare & Pharma market trends
Target
Winncare is a leading European manufacturer of medical devices specifically designed for the care of individuals with loss of autonomy. The company,s product portfolio includes high-tech anti-bedsore mattresses, medicalized beds, and patient-handling solutions aimed at improving the quality of life for the elderly and those in rehabilitation. Operating with an industrial business model, Winncare supplies its essential medical equipment to nursing homes, hospitals, and home-care providers globally. Its value proposition is built on technical innovation and the reliability of its "first-necessity" products, which address the growing healthcare demands of an aging global population. The group,s strategy centers on being a consolidation platform in the specialized medical furniture market, leveraging a robust R&D pipeline to maintain regulatory compliance and clinical efficacy. By integrating digital solutions into its hardware, Winncare ensures better patient monitoring and caregiver efficiency. The company maintains a strong international presence, focusing on expanding its manufacturing and distribution footprint across Europe and North America through both organic innovation and strategic industrial acquisitions.
Ent. Value
[members only]
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Winncare
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 12/2021 | WINNCARE | PHARMAOUEST INDUSTRIES | FRANCE | Medical Devices |
| 02/2021 | SIPAREX | WINNCARE | FRANCE | Medical Devices |
Other operations with Siparex
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2026 | SIPAREX / BPIFRANCE / CARVEST (CRÉDIT AGRICOLE RÉGIONS INVESTISSEMENT) | SATYS ELECTRIC | FRANCE | Cabling & Connectivity |
| 09/2026 | SIPAREX | KOALYS | FRANCE | TIC (Testing, Inspection, Certification) |
| 03/2026 | SIPAREX | ATK SPORTS | ITALY | Outdoor |
| 01/2026 | SIPAREX | 123 ELEC | FRANCE | Specialized E-commerce |
| 01/2026 | SIPAREX / SOCADIF / BNP PARIBAS DEVELOPPEMENT | NOVAKAMP | FRANCE | Aerospace, Naval & Defense |
| 10/2025 | SIPAREX / BPIFRANCE | BRIFER (LA FERROVIAIRE DE LA BRIE) | FRANCE | Railways |
| 04/2025 | SIPAREX | NOOUS | FRANCE | Recruitment / Headhunting |
| 03/2025 | SIPAREX | LABORATOIRE POLIDIS | FRANCE | Medical Consumables |
| 07/2023 | SIPAREX | GROUPE PASSMAN | FRANCE | IT Equipment |
| 05/2023 | SIPAREX | SODIKART | FRANCE | Cycling & Micromobility |
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2026 | REVENIO GROUP CORPORATION | VISIONIX INTERNATIONAL | FRANCE | Diagnostic Equipment |
| 04/2026 | GILEAD SCIENCES | ARCELLX | UNITED STATES | R&D Biotech |
| 03/2026 | RESONETICS | RESOLUTION MEDICAL | UNITED STATES | Medical Devices |
| 03/2026 | ABBOTT LABORATORIES | EXACT SCIENCES | UNITED STATES | Diagnostic Equipment |
| 03/2026 | DEUTSCHE BETEILIGUNGS (DBAG) | HIPP TECHNOLOGY GROUP | GERMANY | Implants & Prosthetics |
| 03/2026 | LONE STAR FUNDS | LONZA CHI | SWITZERLAND | CDMO |
| 02/2026 | CIMG | DAREN TECHNOLOGY | CHINA | R&D Biotech |
| 02/2026 | IMA GROUP | PROSYS | IRELAND | Medical Devices |
| 02/2026 | VIVO CAPITAL | DUTSCHER | FRANCE | Medical Consumables |
| 02/2026 | NORD HOLDING | HALLMARQ VETERINARY IMAGING | UNITED KINGDOM | Diagnostic Equipment |
REFERENCES
Revenue range: REV €100–200M
EBITDA range: €5–25M
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Winncare by Siparex are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: winncare
FAQ
What transaction does this page cover?
What were Winncare’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?